Produkty 82509-41-9

CAS 82509-41-9 występuje w naszej ofercie pod nazwami: 8-Epiloganic acid/ 98.66% (existing batch purity), 8–Epiloganic acid, 8-Epi-Loganic acid, 8-Epiloganic acid, 99.76%, 8-Epi-Loganic acid, ≥98%(HPLC). Oferty producentów: TargetMol, GLPBio, Chemat, MedChemExpress. Dostępne opakowania: 1mg, 5mg, 10mg, 25mg, 50mg, 20mg, 5 mg, 1 mg.

8-Epiloganic acid/ 98.66% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 5
od 1176,01
Zobacz produkt
8–Epiloganic acid
GLPBio
  • opakowanie: 5mg
  • Warianty: 1
od 2352,23
Zobacz produkt
8-Epi-Loganic acid
Chemat
  • opakowanie: 1mg, 20mg
  • Warianty: 2
od 1106,00
Zobacz produkt
8-Epiloganic acid, 99.76%
MedChemExpress
  • opakowanie: 5 mg, 1 mg
  • Warianty: 2
od 1002,36
Zobacz produkt
8-Epi-Loganic acid, ≥98%(HPLC)
Chemat
  • opakowanie: 5mg, 10mg
  • Warianty: 2
od 899,60
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(1S,4aS,6S,7S,7aS)-6-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid (CAS 82509-41-9) to związek chemiczny o wzorze sumarycznym C16H24O10 i masie molowej 376.36 g/mol. Nazwa systematyczna IUPAC: (1S,4aS,6S,7S,7aS)-6-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid. InChIKey: JNNGEAWILNVFFD-OZFVSFPVSA-N.

Dane identyfikacyjne
Wzór sumarycznyC16H24O10
Masa molowa376.36 g/mol
Nazwa IUPAC(1S,4aS,6S,7S,7aS)-6-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid
InChIKeyJNNGEAWILNVFFD-OZFVSFPVSA-N
SMILESC[C@@H]1[C@H](C[C@H]2[C@@H]1[C@@H](OC=C2C(=O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 8-Epiloganic acid, 8-epi-Loganic acid, 8-epi-loganin acid, orb1217622, orb1297154
Powiązane formy tego związku
(1S,4aS,6S,7R,7aS)-6-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid C16H24O10
Izomery (ten sam wzór sumaryczny)
(1S,4aR,7S,7aR)-4a,7-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4-carbaldehyde C16H24O10
[(3aS,5R,6R,7S,7aS)-6,7-diacetyloxy-2-ethoxy-2-methyl-5,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-b]pyran-5-yl]methyl acetate C16H24O10
[(3aR,5R,6R,7S,7aR)-6,7-diacetyloxy-2-ethoxy-2-methyl-5,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-b]pyran-5-yl]methyl acetate C16H24O10
(1S,4aS,7S,7aS)-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid C16H24O10
(2S,3R,4S,5S,6R)-2-[[(1R,2S,3R,5R,6R,8S)-6-hydroxy-2-(hydroxymethyl)-8-methyl-9,10-dioxatetracyclo[4.3.1.02,5.03,8]decan-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol C16H24O10
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[[(1S,2S,4S,5S,6R,10S)-2-(hydroxymethyl)-5-methoxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-10-yl]oxy]oxane-3,4,5-triol C16H24O10
(1S,4aS,7S,7aS)-7-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid C16H24O10
(1S,4aS,5R,7R,7aR)-5-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid C16H24O10